Profile data is unavailable for this security.
About the company
Pharmaniaga Berhad is an investment holding company. The Company is principally engaged in the research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales, and marketing, as well as community pharmacy. The Company operates through three segments: Logistics and distribution, Manufacturing, and Indonesia. The Logistics and distribution is engaged in the distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment is engaged in the manufacturing of pharmaceutical products in Malaysia. Indonesia segment is engaged in the manufacturing and distribution of pharmaceutical and medical products in Indonesia. The Company’s subsidiaries include Idaman Pharma Manufacturing Sdn. Bhd., Pharmaniaga Manufacturing Berhad, Pharmaniaga LifeScience Sdn. Bhd., Pharmaniaga Logistics Sdn. Bhd., and Pharmaniaga Marketing Sdn. Bhd.
- Revenue in MYR (TTM)3.40bn
- Net income in MYR-77.45m
- Incorporated1998
- Employees3.78k
- LocationPharmaniaga Bhd7 Lorong Keluli 1BKawasan Perindustrian BukitRaja Selatan, Seksyen 7SHAH ALAM 40000MalaysiaMYS
- Phone+60 333429999
- Fax+60 333417777
- Websitehttps://pharmaniaga.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kim Forest Enterprise Co Ltd | 60.64m | -19.49m | 287.51m | -- | -- | 3.48 | -- | 4.74 | -2.85 | -2.85 | 8.89 | 11.29 | 0.4986 | 3.34 | 4.31 | -- | -16.02 | -0.8245 | -19.78 | -1.06 | 13.15 | 31.99 | -32.14 | -1.25 | 1.19 | -82.43 | 0.2664 | -- | -38.11 | 12.36 | -341.58 | -- | -8.51 | -- |
Sinco Pharmaceuticals Holdings Ltd | 1.65bn | 27.50m | 289.46m | 278.00 | 10.53 | 0.7098 | 7.62 | 0.1755 | 0.0225 | 0.0225 | 1.35 | 0.3339 | 1.53 | 22.60 | 5.73 | 9,875,025.00 | 2.56 | 6.48 | 6.55 | 20.22 | 12.73 | 14.79 | 1.67 | 3.86 | 1.08 | 28.20 | 0.2859 | 7.21 | 11.82 | 21.66 | -39.03 | -- | 123.63 | -- |
Hyphens Pharma International Ltd | 594.26m | 29.85m | 317.74m | 440.00 | 10.65 | 1.45 | 8.02 | 0.5347 | 0.0277 | 0.0277 | 0.5513 | 0.2037 | 1.45 | 4.65 | 4.89 | 387,715.90 | 7.29 | 8.35 | 12.10 | 14.01 | 36.29 | 37.06 | 5.03 | 5.65 | 1.35 | -- | 0.0939 | 33.00 | 5.10 | 7.12 | -24.52 | 9.63 | -18.70 | 9.35 |
Harima-Kyowa Co., LTD. | 1.85bn | 42.36m | 346.24m | 197.00 | 8.07 | 0.4706 | 7.89 | 0.1867 | 261.75 | 261.75 | 11,459.40 | 4,490.24 | 1.91 | 23.79 | 5.51 | -- | 4.36 | 4.39 | 5.70 | 5.87 | 11.57 | 11.73 | 2.28 | 2.23 | 2.22 | -- | 0.0131 | 17.15 | 2.37 | 5.01 | 1.10 | 3.25 | 34.30 | 3.44 |
Able View Global Inc | 698.44m | 44.26m | 354.76m | 98.00 | 8.11 | 6.71 | 7.83 | 0.5079 | 0.2229 | 0.2229 | 3.52 | 0.2695 | 2.72 | 6.20 | 8.37 | 1,520,406.00 | 17.80 | -- | 30.88 | -- | 24.84 | -- | 6.54 | -- | 1.99 | 7.90 | 0.2017 | -- | 2.58 | -- | 23.46 | -- | -- | -- |
Natural Health Trends Corp. | 201.63m | 2.34m | 379.51m | 138.00 | 161.87 | 2.06 | 124.18 | 1.88 | 0.0434 | 0.0434 | 3.75 | 3.42 | 0.582 | 2.24 | -- | 311,695.70 | 0.6751 | -0.5398 | 0.9333 | -0.7099 | 74.30 | 74.06 | 1.16 | -0.9571 | 2.77 | -- | 0.00 | -- | -10.60 | -25.54 | 81.47 | -54.86 | -26.47 | 6.64 |
Balaxi Pharmaceuticals Ltd | 147.50m | -2.94m | 402.96m | 51.00 | -- | -- | -- | 2.73 | -5.30 | -5.30 | 255.76 | -- | -- | -- | -- | 51,400,510.00 | -- | 31.86 | -- | 46.07 | 42.45 | 32.28 | -1.99 | 15.43 | -- | -- | -- | -- | 20.42 | -- | -3.56 | -- | 314.83 | -- |
Pharmaniaga Berhad | 3.40bn | -77.45m | 439.58m | 3.78k | -- | -- | -- | 0.1291 | -0.0572 | -0.0572 | 2.55 | -0.2056 | 1.82 | 4.59 | 9.57 | -- | -4.06 | -6.88 | -- | -38.45 | 9.04 | 6.64 | -2.23 | -3.66 | 0.2762 | 1.37 | 1.29 | -- | -3.02 | 7.38 | 87.25 | -- | 23.35 | -- |
Sopharma Trading AD | 4.38bn | 76.09m | 526.80m | 2.62k | 6.92 | 1.64 | 3.30 | 0.1203 | 0.8521 | 0.8521 | 49.05 | 3.59 | 2.77 | 0.1565 | 7.98 | 642,620.80 | 4.80 | 2.39 | 14.54 | 7.88 | 98.04 | 98.09 | 1.74 | 1.01 | 0.5952 | 187.59 | 0.615 | -- | 13.02 | 13.26 | 221.67 | 27.86 | 3.70 | -- |
111 Inc - ADR | 9.70bn | -254.83m | 534.06m | 1.66k | -- | -- | -- | 0.0551 | -0.6425 | -0.6425 | 24.55 | -0.9617 | 4.56 | 9.66 | 29.15 | -- | -10.77 | -17.09 | -- | -178.25 | 5.68 | 5.36 | -2.36 | -4.37 | 0.5457 | -32.73 | 0.5781 | -- | 10.59 | 52.95 | 5.80 | -- | -- | -- |
EQL Pharma AB | 115.58m | 9.93m | 550.60m | 21.00 | 56.66 | 7.08 | -- | 4.76 | 0.7642 | 0.7642 | 8.88 | 6.12 | 0.8012 | 1.74 | 4.80 | 12,579,430.00 | 6.89 | 9.02 | 11.90 | 15.27 | 43.55 | 37.95 | 8.59 | 8.29 | 0.5694 | 8.88 | 0.4032 | -- | 1.64 | 39.64 | -26.57 | -- | 32.73 | -- |
Holder | Shares | % Held |
---|---|---|
Lembaga Tabung Angkatan Tenteraas of 31 Mar 2023 | 112.88m | 7.83% |
MIDF Amanah Asset Management Bhd.as of 15 Jul 2020 | 600.00k | 0.04% |
LGT Capital Partners AG (Investment Management)as of 31 May 2023 | 0.00 | 0.00% |
RHB Asset Management Sdn. Bhd.as of 30 Jun 2023 | 0.00 | 0.00% |
Grantham, Mayo, Van Otterloo & Co. LLCas of 30 Sep 2021 | 0.00 | 0.00% |